2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
August 25, 2014|Rheumatology
Author and Disclosure Information
Clinical Algorithm(s)
Clinical algorithms are provided in the original guideline document for the following:
- 2012 American College of Rheumatology (ACR) recommendations update for the treatment of early rheumatoid arthritis (RA), defined as a disease duration <6 months
- 2012 ACR recommendations update for the treatment of established RA, defined as a disease duration ≥6 months or meeting the 1987 ACR classification criteria
- 2012 ACR recommendations update for tuberculosis (TB) screening with biologic agent use
